Merck and Moderna's Phase 3 Win Raises the Stakes for BioNTech and Roche (CORRECTED)

기사 요약

Merck & Moderna's partnership reports first Phase 3 success for personalized cancer vaccine, raising stakes for BioNTech & Genentech's program.